Moneycontrol
HomeNewsBusinessPersonal FinanceIRDAI asks insurers to settle claims as per cashless agreements with hospitals, policy terms

IRDAI asks insurers to settle claims as per cashless agreements with hospitals, policy terms

Insurers can take GI Council and state government-prescribed rates into account while entering into cashless agreements with hospitals

January 19, 2021 / 14:57 IST
Story continues below Advertisement

Insurance regulator IRDAI has directed insurers to settle cashless COVID-19 claims as per the tariff decided by insurers, hospitals and third-party administrators (TPA).

“Insurers shall make efforts to have an agreement with health providers on rates for treatment of Covid-19 similar to other diseases for which rate agreements are in place,” the Insurance Regulatory and Development Authority of India (IRDAI) said in a circular on January 13.

Story continues below Advertisement

“For cashless claims, insurers have been asked to settle claims based on agreed rates. Some insurance companies have agreements with hospitals on treatment charges for infectious diseases. So, even if COVID-19 is not specifically mentioned, it being an infectious disease, some insurers are rightly settling claims as per the agreed rates for infectious diseases,” said MN Sarma, Secretary-General, General Insurance Council (GI Council), the industry association of all non-life and re-insurers in India.

“In cases where insurers do not have agreed rates with hospitals, IRDAI has advised insurers to strive to enter into agreements keeping the state governments/union territories rates as well as General Insurance Council’s reference rates as reference points,” Sarma said.

Agreements with hospitals key

Insurers have cashless agreements in place for regular and non-COVID treatment procedures. “The regulator has advised insurers to go by their tariff, as negotiated with the hospital. If insurers do not have agreements with hospitals on COVID-specific rates, the generic discounts negotiated on room rent and other charges may apply,” said Abhishek Bondia, Co-founder, Securenow.in.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show